Immediate Impact

50 standout
Sub-graph 1 of 25

Citing Papers

Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies
2025 Standout
Targeting KRAS: from metabolic regulation to cancer treatment
2025 Standout
2 intermediate papers

Works of E. Dotor being referenced

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
2019
microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers
2013

Author Peers

Author Last Decade Papers Cites
E. Dotor 262 69 96 168 150 23 451
Anna Maria Elisabeth Walenkamp 261 65 76 115 70 17 451
Jon D. Dorfman 167 77 60 180 77 20 430
T. Giannakakis 363 88 67 78 119 24 453
Viola Barucca 339 110 115 90 115 19 483
Carolina Ortiz 211 69 40 150 79 25 413
K Fischerman 190 80 133 78 129 23 476
Kota Ouchi 243 104 68 152 158 42 470
Line Schmidt Tarpgaard 206 81 89 195 177 27 453
Qirong Geng 108 155 118 161 113 25 446
Edwin M. Cohn 138 113 73 159 239 14 503

All Works

Loading papers...

Rankless by CCL
2026